Farallon Capital Boosts Stake in McKesson Corporation

Institutional investor increases holding in major healthcare distributor

Mar. 16, 2026 at 11:07am

Got story updates? Submit your updates here. ›

Farallon Capital Management LLC, a prominent investment firm, has increased its stake in McKesson Corporation (NYSE:MCK) by 4.0% during the third quarter, according to a recent SEC filing. Farallon now owns 327,100 shares of the healthcare company, making it the 28th largest holding in its portfolio.

Why it matters

This move by Farallon Capital, a respected institutional investor, signals confidence in McKesson's long-term prospects as a leading healthcare services and distribution company. It also highlights the continued interest from major investors in the pharmaceutical supply chain sector.

The details

According to the filing, Farallon Capital Management acquired an additional 12,500 shares of McKesson, bringing its total stake to 327,100 shares. This represents approximately 0.27% of McKesson's outstanding shares. The investment firm cited McKesson's dominant position in pharmaceutical distribution and its diversified healthcare services offerings as reasons for the increased investment.

  • Farallon Capital Management increased its stake in McKesson during the third quarter of the year.

The players

Farallon Capital Management LLC

A prominent investment management firm that focuses on alternative investment strategies.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and healthcare technology solutions.

Got photos? Submit your photos here. ›

The takeaway

Farallon Capital's increased investment in McKesson underscores the healthcare distributor's strong market position and the continued appeal of the pharmaceutical supply chain sector to major institutional investors.